NLM Gateway
A service of the U.S. National Institutes of Health
Your Entrance to
Resources from the
National Library of Medicine
    Home      Term Finder      Limits/Settings      Search Details      History      My Locker        About      Help      FAQ    
Skip Navigation Side Barintended for web crawlers only

Once-Daily Amoxicillin/Clavulanate for Seven Days in Pediatric Group A Streptococcal tonsillopharyngitis.

SYROGIANNOPOULOS GA, GRIVEA IN, BERATIS NG; HELLENIC ANTIBIOTIC-RESISTANT PATHOGENS (HARP) STUDY GROUP; Interscience Conference on Antimicrobial Agents and Chemotherapy (42nd: 2002: San Diego, Calif).

Abstr Intersci Conf Antimicrob Agents Chemother Intersci Conf Antimicrob Agents Chemother. 2002 Sep 27-30; 42: abstract no. G-436.

Univ. of Patras, Med. Sch., Patras, Greece

BACKGROUND: Amoxicillin once-daily for 10 days has been suggested as an effective treatment for Group A streptococcal tonsillopharyngitis (GAS-TP) with potential for better compliance. METHODS: In an ongoing, open-label study of the HARP Study Group, initiated in September '01, children (aged 2-16 yrs) with GAS-TP were randomly assigned to receive amoxicillin/clavulanate (A/C) once-daily (30.6/4.4 mg/kg qd; maximum dose 1,200/171 mg qd) or twice-daily (43.8/6.2 mg/kg/day bid; maximum dose 875/125 mg bid) for 7 days. Post-treatment clinical evaluation and throat culture (TC) were performed at 4-8 (V[2]) and 21-28 (V[3]) days. RESULTS: On 23 April '02 there were 194 children with GAS-TP treated per protocol. The 194 GAS isolates had A/C MIC range: 0.016-0.064 mcg/ml and MIC[90]: 0.032 mcg/ml. The twice-daily A/C regimen had clinical success at V[2] and V[3] in 98% (94/96) and 95% (91/96) of the children, respectively. In the same regimen, eradication of GAS from TC at V[2] and V[3] was observed in 92% (88/96) and 89% (81/91) of the children treated, respectively. The clinical and bacteriological efficacy of the once-daily A/C regimen in children aged <6 and >/= 6 yrs is shown in the following table. CONCLUSIONS: The once-daily A/C (30.6/4.4 mg/kg qd) 7-day regimen had suboptimal bacteriological efficacy. Once-daily A/C had better clinical and bacteriological efficacy in children aged >/= 6 yrs than in children <6 yrs. This difference was more prominent at the 21-28 day post-treatment visit, when the bacteriological efficacy in the <6 yrs age-group was significantly lower than that found in the >/= 6 yrs group.

Publication Types:
  • Meeting Abstracts
Keywords:
  • Amoxicillin
  • Child
  • Clavulanic Acid
  • Humans
  • Periodicity
  • Streptococcus
  • Streptococcus pneumoniae
  • Streptococcus pyogenes
Other ID:
  • GWAIDS0028406
UI: 102268030

From Meeting Abstracts




Contact Us
U.S. National Library of Medicine |  National Institutes of Health |  Health & Human Services
Privacy |  Copyright |  Accessibility |  Freedom of Information Act |  USA.gov